This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Soardi, F. C. Articles by de Mello, M. P. Search for Related Content PubMed PubMed Citation Articles by Soardi, F. C. Articles by de Mello, M. P. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM UniGene Substance via MeSH Genetics Home Reference Related Collections Adrenal and Hypertension

Inhibition of CYP21A2 Enzyme Activity Caused by Novel Missense Mutations Identified in Brazilian and Scandinavian Patients

Laboratório de Genética Molecular Humana (F.C.S., I.F.L., M.P.d.M.), Centro de Biologia Molecular e Engenharia Genética, Departamento de Pediatria/Centro de Investigação em Pediatria (S.H.V.L.-M., G.G.-J.), and Departamento de Clinica Medica (M.T.M.B.), Disciplina de Endocrinologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, 13083-875 Campinas SP, Brasil; and Department of Molecular Medicine and Surgery (M.B., A.W., S.L.), Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden

Address all correspondence and requests for reprints to: Maricilda Palandi de Mello, Ph.D., Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas CBMEG-UNICAMP, Caixa Postal 6010, 13083-875 Campinas, SP, Brasil. E-mail: mmello{at}unicamp.br.

Background: Most patients with 21-hydroxylase deficiency carry CYP21A1P-derived mutations, but an increasing number of novel and rare mutations have been reported in disease-causing alleles.

Objective: Functional effects of three novel (p.G56R, p.L107R, p.L142P) and one recurrent (p.R408C) CYP21A2 mutations were investigated. The degree of enzyme impairment caused by p.H62L alone or combined to p.P453S was also analyzed.

Design: The study included 10 Brazilian and two Scandinavian patients. To determine the deleterious role of each mutant protein, in vitro assays were performed in transiently transfected COS-1 cells. For a correct genotype-phenotype correlation, the enzymatic activities were evaluated toward the two natural substrates, 17-hydroxyprogesterone and progesterone.

Results: Low levels of residual activities obtained for p.G56R, p.L107R, p.L142P, and p.R408C mutants classified them as classical congenital adrenal hyperplasia mutations, whereas the p.H62L showed an activity within the range of nonclassical mutations. Apparent kinetic constants for p.H62L confirmed the nonclassical classification as the substrate binding capacity was within the same magnitude for mutant and normal enzymes. A synergistic effect was observed for the allele bearing the p.H62L+p.P453S combination because it caused a significant reduction in the enzymatic activity.

Conclusions: We describe the functional analysis of five rare missense mutations identified in Brazilian and Scandinavian patients. The p.G56R, p.L107R, and p.L142P are reported for the first time. Most probably these novel mutations are closer to null than the p.I172N, but for the p.G56R, that might not be the case, and the p.H62L is definitely a nonclassical mutation.